Zobrazeno 1 - 10
of 492
pro vyhledávání: '"Lelieveld, D."'
Autor:
Omta, W., Heesbeen, R. van, Pagliero, R., Velden, L. van der, Lelieveld, D., Nellen, M., Kramer, M., Yeong, M., Saeidi, A., Medema, R., Spruit, M., Brinkkemper, S., Klumperman, J., Egan, D., Sub Software Production, Paraveterinairen, Sub Software Technology, LS Vet. Fysiologie en Anatomie, Software Production
Publikováno v:
Assay and Drug Development Technologies, 14(8), 439. Mary Ann Liebert inc
Assay and Drug Development Technologies, 14(8), 439. Mary Ann Liebert Inc.
Assay and Drug Development Technologies, 14(8), 439. Mary Ann Liebert Inc.
High-content screening (HCS) can generate large multidimensional datasets and when aligned with the appropriate data mining tools, it can yield valuable insights into the mechanism of action of bioactive molecules. However, easy-to-use data mining to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3e74a099c69d81eccb3b1d0b0db9f1a
https://dspace.library.uu.nl/handle/1874/342966
https://dspace.library.uu.nl/handle/1874/342966
Autor:
Vernooij L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bate-Eya LT; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Alles LK; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Lee JY; Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, Georgia., Koopmans B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Jonus HC; Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, Georgia., Schubert NA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Schild L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Lelieveld D; Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands., Egan DA; Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands., Kerstjens M; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., Stam RW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Koster J; Department of Oncogenomics, Amsterdam UMC, location AMC, Amsterdam, the Netherlands., Goldsmith KC; Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, Georgia., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. memdolman@gmail.com.; Children's Cancer Institute, Lowy Cancer Research Center, UNSW Sydney, Sydney, NSW, Australia.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Jun; Vol. 20 (6), pp. 1161-1172. Date of Electronic Publication: 2021 Apr 13.
Autor:
Wiggers CRM; Department of Pediatric Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Hubrecht Institute, KNAW and University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Govers AMAP; Department of Pediatric Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Center for Molecular Medicine and Regenerative Medicine Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Lelieveld D; Cell Screening Core, Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands., Egan DA; Cell Screening Core, Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands., Zwaan CM; Prinsess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Hematology and Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Sonneveld E; Prinsess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group (DCOG), Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Coffer PJ; Center for Molecular Medicine and Regenerative Medicine Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Bartels M; Department of Pediatric Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2019 Aug; Vol. 66 (8), pp. e27785. Date of Electronic Publication: 2019 May 01.
Autor:
Giustiniani, Emilia1,2 (AUTHOR) egiustiniani@agro.uba.ar, Giménez, Leonardo3 (AUTHOR), Semmartin, María1,4 (AUTHOR)
Publikováno v:
Environment, Development & Sustainability. Oct2024, Vol. 26 Issue 10, p25113-25131. 19p.
Autor:
van Battum EY; Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands., Verhagen MG; Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands., Vangoor VR; Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands., Fujita Y; Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan., Derijck AAHA; Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands., O'Duibhir E; Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands., Giuliani G; Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands., de Gunst T; InteRNA Technologies B.V., Yalelaan 62, 3584 CM Utrecht, The Netherlands, and., Adolfs Y; Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands., Lelieveld D; Department of Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Egan D; Department of Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Schaapveld RQJ; InteRNA Technologies B.V., Yalelaan 62, 3584 CM Utrecht, The Netherlands, and., Yamashita T; Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan., Pasterkamp RJ; Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands, r.j.pasterkamp@umcutrecht.nl.
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2018 Jan 17; Vol. 38 (3), pp. 613-630. Date of Electronic Publication: 2017 Dec 01.
Autor:
Sachs N; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands., de Ligt J; Center for Molecular Medicine, Department of Genetics, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands., Kopper O; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands., Gogola E; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Bounova G; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands., Weeber F; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Balgobind AV; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands., Wind K; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Gracanin A; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Begthel H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Korving J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., van Boxtel R; Center for Molecular Medicine, Department of Genetics, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands., Duarte AA; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Lelieveld D; Cell Screening Core, Department of Cell Biology, Center for Molecular Medicine, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., van Hoeck A; Center for Molecular Medicine, Department of Genetics, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands., Ernst RF; Center for Molecular Medicine, Department of Genetics, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands., Blokzijl F; Center for Molecular Medicine, Department of Genetics, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands., Nijman IJ; Center for Molecular Medicine, Department of Genetics, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands., Hoogstraat M; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., van de Ven M; Mouse Clinic for Cancer and Aging (MCCA), Preclinical Intervention Unit, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Egan DA; Cell Screening Core, Department of Cell Biology, Center for Molecular Medicine, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Zinzalla V; Pharmacology and Translational Research, Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, 1121 Vienna, Austria., Moll J; Pharmacology and Translational Research, Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, 1121 Vienna, Austria., Boj SF; Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands., Voest EE; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Wessels L; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands; Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Rottenberg S; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Länggassstrasse 122, 3012 Bern, Switzerland., Vries RGJ; Foundation Hubrecht Organoid Technology (HUB), Yalelaan 62, 3584 CM Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands., Cuppen E; Center for Molecular Medicine, Department of Genetics, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands., Clevers H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands. Electronic address: h.clevers@hubrecht.eu.
Publikováno v:
Cell [Cell] 2018 Jan 11; Vol. 172 (1-2), pp. 373-386.e10. Date of Electronic Publication: 2017 Dec 07.
Autor:
Pakina, Viktoria A.1, Iksanova, Evgeniya Z.1, Shikh, Evgeniya V.1, Tumutolova, Oksana M.2, Arutiunian, Karen K.2, Kargina, Irina V.2, Blinov, Kirill D.1, Pilgaev, Fedor P.2, Epishkina, Anna A.3,4, Blinov, Dmitrii S.5, Grebenkin, Evgeny V.3,4, Blinova, Ekaterina V.1,4 bev-sechenov@mail.ru
Publikováno v:
Research Results in Pharmacology. 2024, Vol. 10 Issue 2, p17-26. 10p.
Autor:
van Heesbeen RGHP; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Raaijmakers JA; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Tanenbaum ME; Hubrecht Institute, The Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, the Netherlands., Halim VA; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Biomolecular Mass Spectrometry and Proteomics Group, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Lelieveld D; Cell Screening Core, Department of Cell Biology, Center for Molecular Medicine, University Medical Centre, Utrecht, The Netherlands., Lieftink C; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Heck AJR; Biomolecular Mass Spectrometry and Proteomics Group, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Egan DA; Cell Screening Core, Department of Cell Biology, Center for Molecular Medicine, University Medical Centre, Utrecht, The Netherlands., Medema RH; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. r.medema@nki.nl.
Publikováno v:
Chromosoma [Chromosoma] 2017 Aug; Vol. 126 (4), pp. 473-486. Date of Electronic Publication: 2016 Jun 29.
Publikováno v:
Molecular Pain. 2/7/2024, p1-15. 15p.
Autor:
Pagliero RJ; 1 Department of Cell Biology, University Medical Center Utrecht (UMCU) , Utrecht, the Netherlands ., D'Astolfo DS; 1 Department of Cell Biology, University Medical Center Utrecht (UMCU) , Utrecht, the Netherlands .; 2 KNAW-Hubrecht Institute , Utrecht, the Netherlands ., Lelieveld D; 1 Department of Cell Biology, University Medical Center Utrecht (UMCU) , Utrecht, the Netherlands ., Pratiwi RD; 1 Department of Cell Biology, University Medical Center Utrecht (UMCU) , Utrecht, the Netherlands ., Aits S; 3 Cell Death and Metabolism Unit, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center , Copenhagen, Denmark ., Jaattela M; 3 Cell Death and Metabolism Unit, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center , Copenhagen, Denmark ., Martin NI; 4 Department of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University , Utrecht, the Netherlands ., Klumperman J; 1 Department of Cell Biology, University Medical Center Utrecht (UMCU) , Utrecht, the Netherlands ., Egan DA; 1 Department of Cell Biology, University Medical Center Utrecht (UMCU) , Utrecht, the Netherlands .
Publikováno v:
Assay and drug development technologies [Assay Drug Dev Technol] 2016 Oct; Vol. 14 (8), pp. 489-510. Date of Electronic Publication: 2016 Sep 22.